Drawing for LYV

USPTO serial 98275822

LYV

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
QUEEN, ESTHER FELICIA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with LYV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brittany L. Kulwicki

Brittany L. Kulwicki Calfee, Halter & Griswold LLP1405 East Sixth StreetThe Calfee BuildingCleveland, OH 44114

Goods and services

ClassDescriptionStatusFirst use
005Botulinum toxin for medical use for use in the treatment of hyperhidrosis, excessive eye blinking, migraines, spastic disorders, cervical dystonia, detrusor hyperactivity, neuropathy pain, and wrinkles; Homeopathic supplements; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Non-medicated, therapeutic skin creams for the treatment of inflammation and joint pain; Nutritional supplements; Probiotic supplements; Stem cells for medical purposes; Synthetic peptides for the treatment of inflammation, high blood pressure, immune system, blood clots, weight control, muscle growth, healing, hair loss, aging, sleep support, swelling, decreased energy, and mood support; Therapeutic agents for weight control and appetite suppression; Therapeutic pharmaceutical for the treatment of appetite, namely, appetite suppression and weight, namely, weight control; Vitamin supplementsACTIVEJan 1, 2021
035On-line retail store services featuring a wide variety of consumer goods of others; On-line retail store services featuring a wide variety of health and wellness goods; Retail store services featuring a wide variety of consumer goods of othersACTIVE—
044Consulting services in the field of hormone replacement therapy; Cosmetic body care services provided by health spas; Cosmetic skin care services, namely, facials; Cryotherapy services; Health care services, namely, stem cell therapy, infrared light-emitting diode (LED) therapy, platelet rich plasma (PRP) injections, hyperbaric oxygen therapy (HBOT), ozone therapy, minimally invasive threading therapy, facial and body composition scanning, medical testing of blood panels, micronutrients, food sensitivity, gut biome, heavy metal, genetic, and genotyping; Health spa services, namely, cosmetic body care services; Infrared sauna services; Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Medical spa services, namely, minimally and non-invasive cosmetic and body fitness therapies; Metabolic testing for nutraceutical needs; Providing information about dietary supplements and nutrition; Providing medical aesthetic procedures, namely, treating the skin with dermal fillers and botulinum toxin; Providing weight loss programs and cosmetic body care services in the nature of non-surgical body contouring; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial fine lines; Vitamin therapyACTIVEJan 1, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2026EX3GSOU EXTENSION 3 GRANTED—
Oct 29, 2026EXT3SOU EXTENSION 3 FILED—
Oct 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 24, 2026EX2GSOU EXTENSION 2 GRANTED—
Jul 23, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 30, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 30, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Apr 30, 2026PETGPETITION TO REVIVE-GRANTED—
Apr 30, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Apr 28, 2026EXT2SOU EXTENSION 2 FILED—
Oct 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Oct 10, 2025EXT1SOU EXTENSION 1 FILED—
Oct 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 6, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 24, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 24, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jun 24, 2024CNSLSUSPENSION LETTER WRITTEN—
Jun 23, 2024DOCKASSIGNED TO EXAMINER—
Feb 8, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 8, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance